Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients Alfredo TorresJeremy L. RamdialCharles L. Vogel Review 21 March 2019 Pages: 253 - 260
Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy Maysa M. Abu-KhalafAnton SafonovRaymond Russell Review 24 April 2019 Pages: 261 - 270
A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer S. SperanskyP. SerafiniN. H. Bishopric Preclinical study Open access 20 April 2019 Pages: 271 - 289
Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer Chunyi GaoXiaoyu YuanGuohua Wang Preclinical study 20 April 2019 Pages: 291 - 301
Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial) Jennifer R. BellonHao GuoSara M. Tolaney Clinical Trial 19 April 2019 Pages: 303 - 310
Comparing long-term local recurrence rates of surgical and non-surgical management of close anterior margins in breast conserving surgery George BoundoukiJoseph Ryan Wong Sik HeeJames R. Harvey Clinical trial 22 April 2019 Pages: 311 - 319
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases Maria J. SambadeGrace PrinceCarey Anders Clinical trial 23 April 2019 Pages: 321 - 328
Breast desmoid tumor management in France: toward a new strategy Ludwig Duazo-CassinSophie Le GuellecCharlotte Vaysse Clinical trial 23 April 2019 Pages: 329 - 335
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case–control analysis Maoli WangHongliang ChenMingdi Zhang Clinical trial 24 April 2019 Pages: 337 - 347
The impact of communication style on patient satisfaction Amelia A. TrantBorbala SzekelyLajos Pusztai Clinical trial 25 April 2019 Pages: 349 - 356
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311 Stephen. P. AcklandV. Gebskifor Breast Cancer Trials Ltd (formerly known as the Australia and New Zealand Breast Cancer Trials Group) Clinical trial 26 April 2019 Pages: 357 - 365
The influence of neoadjuvant chemotherapy on complications of immediate DIEP flap breast reconstructions J. BeugelsJ. L. W. MeijvogelR. R. W. J. van der Hulst Clinical trial Open access 27 April 2019 Pages: 367 - 375
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone Ivana SestakMiguel MartínMichael Gnant Clinical trial Open access 30 April 2019 Pages: 377 - 386
Circulating adipose stromal cells as a response biomarker in phase II energy balance trials of obese breast cancer survivors and high-risk women Hailey A. BakerCarol J. FabianBruce F. Kimler Clinical trial 30 April 2019 Pages: 387 - 394
Establishing physical activity in breast cancer: self-report versus activity tracker Chad W. WagonerSeul K. ChoiKirsten A. Nyrop Clinical trial 30 April 2019 Pages: 395 - 400
Does every woman presenting with malignant calcifications require a post lumpectomy mammogram? Hálio Rodrigues-DuarteThiemo J. A. van NijnattenMaxine S. Jochelson Epidemiology 20 April 2019 Pages: 401 - 406
Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa Catherine SchairerAhmed HablasAmr S. Soliman Epidemiology 22 April 2019 Pages: 407 - 417
Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study Hak Min LeeBo Wook KimIlkyun Lee Epidemiology 24 April 2019 Pages: 419 - 427
Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy Leticia VarellaAkaolisa Samuel EziokwuAlberto J. Montero Epidemiology 20 March 2019 Pages: 429 - 434
Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes Anna WeissHeather LinRosa F. Hwang Epidemiology 25 April 2019 Pages: 435 - 444
Shared-patient physician networks and their impact on the uptake of genomic testing in breast cancer Jason RotterLauren WilsonMichaela Dinan Epidemiology 26 April 2019 Pages: 445 - 451
Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients Jung Youn KimDae-Won LeeSukil Kim Epidemiology 26 April 2019 Pages: 453 - 460
Racial disparities in surveillance mammography among older breast cancer survivors Jimmitti TeysirNana GegechkoriJenny J. Lin Epidemiology 26 April 2019 Pages: 461 - 467
Noncompliance with palliative systemic therapy in patients with distant metastatic breast cancer: a blind spot for oncologists? Constanze ElfgenGiacomo MontagnaUwe Güth Epidemiology 02 May 2019 Pages: 469 - 476
Oral or intravenous vinorelbine plus capecitabine in heavily pretreated HER2 negative metastatic breast cancer; similar effect or quality of life? Kadri Altundag Letter to the Editor 23 April 2019 Pages: 477 - 477
Classifying sarcopenia: using median value or cut-off values? Onur BasOmer Dizdar Letter to the Editor 25 April 2019 Pages: 479 - 479
Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) Christoph J. RagethElizabeth A. M. O’FlynnZsuzsanna Varga Correction Open access 31 May 2019 Pages: 481 - 482
